JCI - Citations to Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Citations to this article

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

Douglas Marvel, Dmitry I. Gabrilovich

Douglas Marvel, Dmitry I. Gabrilovich

Published July 13, 2015
Citation Information: J Clin Invest. 2015;125(9):3356-3364. https://doi.org/10.1172/JCI80005.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2009	Total
Citations:	20	34	51	65	80	77	62	71	79	63	7	1	610

Citation information

Citations to this article in year 2021 (80)

Title and authors	Publication	Year
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells MY Lee, Y Robbins, C Sievers, J Friedman, HA Sater, PE Clavijo, N Judd, E Tsong, C Silvin, P Soon-Shiong, MR Padget, J Schlom, J Hodge, C Hinrichs, C Allen	Journal for ImmunoTherapy of Cancer	2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor BD Curti, Y Koguchi, RS Leidner, AS Rolig, ER Sturgill, Z Sun, Y Wu, V Rajamanickam, B Bernard, I Hilgart-Martiszus, CB Fountain, G Morris, N Iwamoto, T Shimada, SC Chang, PG Traber, E Zomer, JR Horton, H Shlevin, WL Redmond	Journal for ImmunoTherapy of Cancer	2021
Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment MY Chou, MH Yang	International journal of molecular sciences	2021
Phospholipase A2 Drives Tumorigenesis and Cancer Aggressiveness through Its Interaction with Annexin A1 L Vecchi, TG Araújo, FV de Vasconcelos Azevedo, ST Mota, V de Melo Rodrigues Ávila, MA Ribeiro, LR Goulart	Cells	2021
Advancing to the era of cancer immunotherapy Y Wang, M Wang, HX Wu, RH Xu		2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes AK Pullikuth, ED Routh, KD Zimmerman, J Chifman, JW Chou, MH Soike, G Jin, J Su, Q Song, MA Black, C Print, D Bedognetti, M Howard-McNatt, SS ONeill, A Thomas, CD Langefeld, AB Sigalov, Y Lu, LD Miller	Frontiers in Oncology	2021
Translational Research in Breast Cancer DY Noh, W Han, M Toi	Translational Research in Breast Cancer	2021
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer K Li, H Shi, B Zhang, X Ou, Q Ma, Y Chen, P Shu, D Li, Y Wang	Signal Transduction and Targeted Therapy	2021
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives X Mao, J Xu, W Wang, C Liang, J Hua, J Liu, B Zhang, Q Meng, X Yu, S Shi	Molecular Cancer	2021
HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression X Li, X Su, R Liu, Y Pan, J Fang, L Cao, C Feng, Q Shang, Y Chen, C Shao, Y Shi	Oncogene	2021
Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches LH Truong, S Pauklin	Cancers	2021
Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells W Huang, Y Liu, A Luz, M Berrong, JN Meyer, Y Zou, E Swann, P Sundaramoorthy, Y Kang, S Jauhari, W Lento, N Chao, L Racioppi	Frontiers in immunology	2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells AS Qadir, JP Guégan, C Ginestier, A Chaibi, A Bessede, E Charafe-Jauffret, M Macario, V Lavoué, T de la Motte Rouge, C Law, J Vilker, H Wang, E Stroup, MJ Schipma, B Bridgeman, AE Murmann, Z Ji, P Legembre, ME Peter	iScience	2021
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes KK Wong, R Hassan, NS Yaacob	Frontiers in Oncology	2021
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review M Farshidpour, M Ahmed, S Junna, JL Merchant	World journal of gastrointestinal oncology	2021
From Good to Bad: The Opposing Effects of PTHrP on Tumor Growth, Dormancy, and Metastasis Throughout Cancer Progression CM Edwards, RW Johnson	Frontiers in Oncology	2021
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells N Gupta, S Gaikwad, I Kaushik, SE Wright, MM Markiewski, SK Srivastava	International journal of molecular sciences	2021
Lipid Metabolism in Tumor Immunity Y Li		2021
Myeloid Cell Mediated Ilmmune Suppression in Pancreatic Cancer SB Kemp, MP di Magliano, HC Crawford	CMGH Cellular and Molecular Gastroenterology and Hepatology	2021
Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity R Okada, T Kato, A Furusawa, F Inagaki, H Wakiyama, PL Choyke, H Kobayashi		2021
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy NC DeVito, M Sturdivant, B Thievanthiran, C Xiao, MP Plebanek, AK Salama, GM Beasley, A Holtzhausen, V Novotny-Diermayr, JH Strickler, BA Hanks	Cell Reports	2021
TGF-β Increases MFGE8 Production in Myeloid-Derived Suppressor Cells to Promote B16F10 Melanoma Metastasis H Lim, T Yang, W Lee, SG Park	Biomedicines	2021
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy C Zalfa, S Paust	Frontiers in immunology	2021
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells MJ Dean, JB Ochoa, MD Sanchez-Pino, J Zabaleta, J Garai, LD Valle, D Wyczechowska, LB Baiamonte, P Philbrook, R Majumder, RS Heide, L Dunkenberger, RP Thylur, B Nossaman, WM Roberts, AG Chapple, J Wu, C Hicks, J Collins, B Luke, R Johnson, HK Koul, CA Rees, CR Morris, J Garcia-Diaz, AC Ochoa	Frontiers in immunology	2021
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation H Tao, M Liu, Y Wang, S Luo, Y Xu, B Ye, L Zheng, K Meng, L Li	Frontiers in immunology	2021
Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells EC Lin, SW Chen, LK Chen, TA Lin, YX Wu, CC Juan, YI Chang	Frontiers in Nutrition	2021
Realization of Osteolysis, Angiogenesis, Immunosuppression, and Drug Resistance by Extracellular Vesicles: Roles of RNAs and Proteins in Their Cargoes and of Ectonucleotidases of the Immunosuppressive Adenosinergic Noncanonical Pathway in the Bone Marrow Niche of Multiple Myeloma T Watanabe	Cancers	2021
Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications AS Basheer, F Abas, I Othman, R Naidu	Cancers	2021
Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1–Dependent TGFβ1 Activation and Suppressing Immunity in Bone Marrow C Zhang, X Xu, T Trotter, P Gowda, Y Lu, M Suto, A Javed, J Murphy-Ullrich, J Li, Y Yang	Molecular cancer therapeutics	2021
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers GS Netti, R Franzin, A Stasi, F Spadaccino, AD Strologo, B Infante, L Gesualdo, G Castellano, E Ranieri, G Stallone	Cells	2021
BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells X Zhang, Y Liu, L Dai, G Shi, J Deng, Q Luo, Q Xie, L Cheng, C Li, Y Lin, Q Wang, P Fan, H Zhang, X Su, S Zhang, Y Yang, X Hu, Q Gong, D Yu, L Zheng, H Deng	Oncogene	2021
The Potential Regulatory Roles of Circular RNAs in Tumor Immunology and Immunotherapy Z Fang, C Jiang, S Li	Frontiers in immunology	2021
Immunopathogenesis of Craniotomy Infection and Niche-Specific Immune Responses to Biofilm SD de Morais, G Kak, JP Menousek, T Kielian	Frontiers in immunology	2021
Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL G Ferrer, B Jung, PY Chiu, R Aslam, F Palacios, AN Mazzarello, S Vergani, D Bagnara, SS Chen, S Yancopoulos, A Xochelli, XJ Yan, JA Burger, JC Barrientos, JE Kolitz, SL Allen, K Stamatopoulos, KR Rai, B Sherry, N Chiorazzi	Leukemia	2021
Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors R Qiu, Y Zhong, Q Li, Y Li, H Fan	Frontiers in Cell and Developmental Biology	2021
Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma W Jiang, Y Li, S Zhang, G Kong, Z Li	Oncology Letters	2021
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects T Li, T Liu, W Zhu, S Xie, Z Zhao, B Feng, H Guo, R Yang	Clinical Medicine Insights. Oncology	2021
The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment L Gong, DL Kwong, W Dai, P Wu, Y Wang, AW Lee, XY Guan	Frontiers in Oncology	2021
Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases Z Ling, C Yang, J Tan, C Dou, Y Chen	Cellular and Molecular Life Sciences	2021
Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma J Huang, P Song, K Hang, Z Chen, Z Zhu, Y Zhang, J Xu, J Qin, B Wang, W Qu, Z Huang, C Liang	Frontiers in immunology	2021
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy K Arvanitakis, I Mitroulis, G Germanidis	Cancers	2021
Myeloid cells in COVID-19 microenvironment G Qin, S Liu, L Yang, W Yu, Y Zhang	Signal Transduction and Targeted Therapy	2021
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies S Kapor, JF Santibanez	Journal of Clinical Medicine	2021
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection ST Gobran, P Ancuta, NH Shoukry	Frontiers in immunology	2021
Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein EI Lesnova, OV Masalova, KY Permyakova, VV Kozlov, TN Nikolaeva, AV Pronin, VT Valuev-Elliston, AV Ivanov, AA Kushch	International journal of molecular sciences	2021
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells S Lin, X Zhang, G Huang, L Cheng, J Lv, D Zheng, S Lin, S Wang, Q Wu, Y Long, B Li, W Wei, P Liu, D Pei, Y Li, Z Wen, S Cui, P Li, X Sun, Y Wu, Y Yao	Oncogene	2021
Immune Modulation of Metastatic Niche Formation in the Bone X Cheng, Z Wang	Frontiers in immunology	2021
Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments F Gsottberger, C Brandl, K Wendland, S Petkovic, C Emmerich, R Erber, C Geppert, A Hartmann, A Mackensen, L Nitschke, F Müller	International journal of molecular sciences	2021
Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma‑associated myeloid‑derived suppressor cells N Angergóra, K WęgierekCiura, A Szczygieł, J Mierzejewska, E PajtaszPiasecka, J Rossowska	Oncology Letters	2021
Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas—Challenges and Perspectives B Kaminska, N Ochocka, P Segit	Cells	2021
Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study A Ottaiano, A Petito, M Santorsola, V Gigantino, M Capuozzo, D Fontanella, RD Franco, V Borzillo, S Buonopane, V Ravo, E Scipilliti, G Totaro, M Serra, G Ametrano, R Penta, F Tatangelo, G Scognamiglio, AD Mauro, MD Bonito, M Napolitano, S Scala, G Rea, S Santagata, A Lombardi, A Grimaldi, C Caputo, A Crispo, E Celentano, GD Feo, L Circelli, G Savarese, R Ruggiero, F Perri, V Granata, G Botti, M Caraglia, G Nasti, P Muto	Cancers	2021
PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas H Zhang, J He, Z Dai, Z Wang, X Liang, F He, Z Xia, S Feng, H Cao, L Zhang, Q Cheng	Frontiers in immunology	2021
SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells S Xia, J Wu, W Zhou, M Zhang, K Zhao, J Liu, D Tian, J Liao	Cell Death and Disease	2021
Neutrophil in the Pancreatic Tumor Microenvironment L Jin, HS Kim, J Shi	Biomolecules	2021
Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer X Ren, J Xiao, W Zhang, F Wang, Y Yan, X Wu, Z Zeng, Y He, W Yang, W Liao, Y Ding, L Liang	Cell Death and Disease	2021
Intratumoral Injection of a Human Papillomavirus Therapeutic Vaccine-Induced Strong Anti-TC-1-Grafted Tumor Activity in Mice Y Che, Y Yang, J Suo, C Chen, X Wang	Cancer management and research	2021
Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor Response EF Goode, ET Torres, S Irshad	Frontiers in Molecular Biosciences	2021
Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients Z Wang, R Jiang, Q Li, H Wang, Q Tao, Z Zhai	Journal of Clinical Medicine	2021
Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma Y Chen, J Zhao	Cell Transplantation	2021
Treatment With Endothelin-A Receptor Antagonist BQ123 Attenuates Acute Inflammation in Mice Through T-Cell-Dependent Polymorphonuclear Myeloid-Derived Suppressor Cell Activation Z Chen, X Zhang, S Lv, Z Xing, M Shi, X Li, M Chen, S Zuo, Y Tao, G Xiao, J Liu, Y He	Frontiers in immunology	2021
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question SJ dit Hreich, J Benzaquen, P Hofman, V Vouret-Craviari	Purinergic Signalling	2021
Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models M Sahraei, M Bose, JA Sanders, C De, L DasRoy, S Nath, CR Brouwer, P Mukherjee	International journal of molecular sciences	2021
Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells T Burster, R Traut, Z Yermekkyzy, K Mayer, MA Westhoff, J Bischof, U Knippschild	Frontiers in Cell and Developmental Biology	2021
Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells G Gabriely, D Ma, S Siddiqui, L Sun, NP Skillin, H Abou-El-Hassan, TG Moreira, D Donnelly, AP da Cunha, M Fujiwara, LR Walton, A Patel, R Krishnan, SS Levine, BC Healy, RM Rezende, G Murugaiyan, HL Weiner	iScience	2021
Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma FM Uckun	Frontiers in Oncology	2021
Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy X Li, J Zhong, X Deng, X Guo, Y Lu, J Lin, X Huang, C Wang	Frontiers in immunology	2021
Immunotherapy Resistance in Glioblastoma EJ Wang, JS Chen, S Jain, RA Morshed, AF Haddad, S Gill, AS Beniwal, MK Aghi	Frontiers in Genetics	2021
Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects. Chowdhury S, Bappy MH, Clocchiatti-Tuozzo S, Cheeti S, Chowdhury S, Patel V	Cureus	2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma Tumino N, Weber G, Besi F, Del Bufalo F, Bertaina V, Paci P, Quatrini L, Antonucci L, Sinibaldi M, Quintarelli C, Maggi E, De Angelis B, Locatelli F, Moretta L, Vacca P, Caruana I	Journal of Hematology & Oncology	2021
Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease Bhat DK, Olkhanud PB, Gangaplara A, Seifuddin F, Pirooznia M, Biancotto A, Fantoni G, Pittman C, Francis B, Dagur PK, Saxena A, McCoy JP, Pfeiffer RM, Fitzhugh CD	Frontiers in immunology	2021
Hypoxic tumor-derived exosomal circular RNA SETDB1 promotes invasive growth and EMT via the miR-7/Sp1 axis in lung adenocarcinoma. Xu L, Liao WL, Lu QJ, Zhang P, Zhu J, Jiang GN		2021
LOX-1 and cancer: an indissoluble liaison Murdocca M, De Masi C, Pucci S, Mango R, Novelli G, Di Natale C, Sangiuolo F	Cancer Gene Therapy	2021
Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis. Matos A, Magalhães SMM, Rauh MJ	Advances in experimental medicine and biology	2021
Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds. Fontana F, Bartolo R, Santos HA	Advances in experimental medicine and biology	2021
IL-6 Promotes the Proliferation and Immunosuppressive Function of Myeloid-Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer Zheng Z, Zheng X, Zhu Y, Yao Z, Zhao W, Zhu Y, Sun F, Mu X, Wang Y, He W, Liu Z, Wu K, Zheng J	BioMed Research International	2021
TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer Gneo L, Rizkalla N, Hejmadi R, Mussai F, de Santo C, Middleton G	Cancer Immunology, Immunotherapy	2021
CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients Uckun FM, Watts J		2021
Revisiting the outstanding questions in cancer nanomedicine with a future outlook. Sudheesh MS, Pavithran K, M S		2021
How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications Van Acker HH, Ma S, Scolaro T, Kaech SM, Mazzone M	Trends in Immunology	2021
Nitrogen-Doped Carbon Nanotube Cups for Cancer Therapy Burkert SC, He X, Shurin GV, Nefedova Y, Kagan VE, Shurin MR, Star A		2021

Advertisement